Overview

Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
To reduce antipsychotics to under 1000mg in patients with schizophrenia taking more than 1000mg/day and to evaluate relationship between relapse and cognitive function.
Phase:
N/A
Details
Lead Sponsor:
Juntendo University
Treatments:
Antipsychotic Agents
Aripiprazole
Haloperidol
Haloperidol decanoate
Methotrimeprazine
Olanzapine
Paliperidone Palmitate
Perphenazine
Quetiapine Fumarate
Risperidone